165 related articles for article (PubMed ID: 23642455)
1. Harpagoside: from Kalahari Desert to pharmacy shelf.
Georgiev MI; Ivanovska N; Alipieva K; Dimitrova P; Verpoorte R
Phytochemistry; 2013 Aug; 92():8-15. PubMed ID: 23642455
[TBL] [Abstract][Full Text] [Related]
2. Harpagoside Content in Devil's Claw Extracts.
Kondamudi N; Turner MW; McDougal OM
Nat Prod Commun; 2016 Sep; 11(9):1215-1216. PubMed ID: 30807002
[TBL] [Abstract][Full Text] [Related]
3. Effects of Devil's Claw (Harpagophytum procumbens) on the multidrug transporter ABCB1/P-glycoprotein.
Romiti N; Tramonti G; Corti A; Chieli E
Phytomedicine; 2009 Dec; 16(12):1095-100. PubMed ID: 19577448
[TBL] [Abstract][Full Text] [Related]
4. Effect of the major glycosides of Harpagophytum procumbens (Devil's Claw) on epidermal cyclooxygenase-2 (COX-2) in vitro.
Abdelouahab N; Heard C
J Nat Prod; 2008 May; 71(5):746-9. PubMed ID: 18412394
[TBL] [Abstract][Full Text] [Related]
5. The Fight against Infection and Pain: Devil's Claw (
Gxaba N; Manganyi MC
Molecules; 2022 Jun; 27(11):. PubMed ID: 35684573
[No Abstract] [Full Text] [Related]
6. Devil's Claw-a review of the ethnobotany, phytochemistry and biological activity of Harpagophytum procumbens.
Mncwangi N; Chen W; Vermaak I; Viljoen AM; Gericke N
J Ethnopharmacol; 2012 Oct; 143(3):755-71. PubMed ID: 22940241
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of devil's claw (secondary root of Harpagophytum procumbens) extract and harpagoside on cytokine production in mouse macrophages.
Inaba K; Murata K; Naruto S; Matsuda H
J Nat Med; 2010 Apr; 64(2):219-22. PubMed ID: 20177800
[TBL] [Abstract][Full Text] [Related]
8. The interaction potential of herbal medicinal products: a luminescence-based screening platform assessing effects on cytochrome P450 and its use with devil's claw (Harpagophyti radix) preparations.
Modarai M; Suter A; Kortenkamp A; Heinrich M
J Pharm Pharmacol; 2011 Mar; 63(3):429-38. PubMed ID: 21749392
[TBL] [Abstract][Full Text] [Related]
9. Quality control of Harpagophytum procumbens and its related phytopharmaceutical products by means of NIR-FT-Raman spectroscopy.
Baranska M; Schulz H; Siuda R; Strehle MA; Rösch P; Popp J; Joubert E; Manley M
Biopolymers; 2005 Jan; 77(1):1-8. PubMed ID: 15558669
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of iNOS expression in rat mesangial cells by special extracts of Harpagophytum procumbens derives from harpagoside-dependent and independent effects.
Kaszkin M; Beck KF; Koch E; Erdelmeier C; Kusch S; Pfeilschifter J; Loew D
Phytomedicine; 2004 Nov; 11(7-8):585-95. PubMed ID: 15636171
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of harpagoside in horses after intragastric administration of a Devil's claw (Harpagophytum procumbens) extract.
Axmann S; Hummel K; Nöbauer K; Razzazi-Fazeli E; Zitterl-Eglseer K
J Vet Pharmacol Ther; 2019 Jan; 42(1):37-44. PubMed ID: 30242850
[TBL] [Abstract][Full Text] [Related]
12. What the devil is in your phytomedicine? Exploring species substitution in Harpagophytum through chemometric modeling of 1H-NMR and UHPLC-MS datasets.
Mncwangi NP; Viljoen AM; Zhao J; Vermaak I; Chen W; Khan I
Phytochemistry; 2014 Oct; 106():104-115. PubMed ID: 25041697
[TBL] [Abstract][Full Text] [Related]
13. Iridoid glycosides from Harpagophytum procumbens D.C. (devil's claw).
Qi J; Chen JJ; Cheng ZH; Zhou JH; Yu BY; Qiu SX
Phytochemistry; 2006 Jul; 67(13):1372-7. PubMed ID: 16857222
[TBL] [Abstract][Full Text] [Related]
14. Rapid measurement and evaluation of the effect of drying conditions on harpagoside content in Harpagophytum procumbens (devil's claw) root.
Joubert E; Manley M; Gray BR; Schulz H
J Agric Food Chem; 2005 May; 53(9):3493-502. PubMed ID: 15853393
[TBL] [Abstract][Full Text] [Related]
15. Effect of isolated fractions of Harpagophytum procumbens D.C. (devil's claw) on COX-1, COX-2 activity and nitric oxide production on whole-blood assay.
Anauate MC; Torres LM; de Mello SB
Phytother Res; 2010 Sep; 24(9):1365-9. PubMed ID: 20812280
[TBL] [Abstract][Full Text] [Related]
16. Estimation of the relative antiinflammatory efficacies of six commercial preparations of Harpagophytum procumbens (Devil's Claw).
Ouitas NA; Heard C
Phytother Res; 2010 Mar; 24(3):333-8. PubMed ID: 19610038
[TBL] [Abstract][Full Text] [Related]
17. Devil's claw (Harpagophytum procumbens) and chronic inflammatory diseases: A concise overview on preclinical and clinical data.
Menghini L; Recinella L; Leone S; Chiavaroli A; Cicala C; Brunetti L; Vladimir-Knežević S; Orlando G; Ferrante C
Phytother Res; 2019 Sep; 33(9):2152-2162. PubMed ID: 31273865
[TBL] [Abstract][Full Text] [Related]
18. Harpagoside suppresses lipopolysaccharide-induced iNOS and COX-2 expression through inhibition of NF-kappa B activation.
Huang TH; Tran VH; Duke RK; Tan S; Chrubasik S; Roufogalis BD; Duke CC
J Ethnopharmacol; 2006 Mar; 104(1-2):149-55. PubMed ID: 16203115
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory and analgesic effects of an aqueous extract of Harpagophytum procumbens.
Lanhers MC; Fleurentin J; Mortier F; Vinche A; Younos C
Planta Med; 1992 Apr; 58(2):117-23. PubMed ID: 1529021
[TBL] [Abstract][Full Text] [Related]
20. DNA Barcode Authentication of Devil's Claw Herbal Dietary Supplements.
Diaz-Silveira GL; Deutsch J; Little DP
Plants (Basel); 2021 Sep; 10(10):. PubMed ID: 34685813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
